Customize your JAMA Network experience by selecting one or more topics from the list below.
Copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2002
To assess sexually active adolescents' attitudes toward 3 screening collection techniques for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis using first-void urine (FVU), self-collected vaginal swab specimens, and pelvic examination with clinician-collected endocervical swab specimens.
Participants completed a preexamination health survey, provided FVU and self-collected vaginal swab samples, and had a pelvic examination with endocervical swab specimen collection. In a confidential postexamination interview, patients ranked the 3 screening techniques according to preference and responded to qualitative positive and negative descriptors to evaluate each technique.
San Francisco area health maintenance organization and university clinics.
A convenience sample of 155 ethnically diverse females aged 12 to 21 years, who were sexually active and were to have a pelvic examination.
Main Outcome Measures
Adolescents' preferences for and evaluations of 3 sexually transmitted disease screening techniques.
Participants preferred the FVU test for sexually transmitted disease screening over the pelvic examination and the self-administered vaginal swab test (P<.001). These results were consistent when controlling for potentially mitigating experiences, including previous pelvic examination, tampon or condom use, and prior pregnancy. In evaluating what they liked and disliked about each of the 3 screening methods, participants described the FVU most positively, the pelvic examination most negatively, and the vaginal swab technique slightly less positively than the FVU.
Most sexually active adolescents attending clinics for pelvic examination prefer to be screened for sexually transmitted diseases first by the FVU, second by the self-collected vaginal swab test, and last by the pelvic examination.
THE RATE of chlamydial infection remains epidemic among 15- to 19-year-old females, with 2359 cases in every 10 000.1 All major health policy organizations recommend annual chlamydial screening for sexually active adolescent females.2-4 The nucleic acid amplification technique applied to urine samples provides a sensitive noninvasive method to screen adolescents for Chlamydia trachomatis and Neisseria gonorrhoeae5,6 and are more cost-effective compared with pelvic examinations.7 Recently, self-collected vaginal swab tests have been successfully implemented as another method of obtaining sexually transmitted disease (STD) specimens from adolescent and adult women,8-10 although this technique awaits approval by the Food and Drug Administration (Rockville, Md). Yet, such STD testing advances have not resulted in universal C trachomatis screening in adolescent females since currently fewer than 1 in 5 eligible adolescents are screened for chlamydia.11
Why is the screening rate so poor? Clinician-linked barriers to screening have been explored,12-14 including lack of time and skill in performing pelvic examinations and in taking sexual histories. Adolescent-linked barriers include fear of the pelvic examination.7,12,15,16 However, before recommending universal adoption of any new STD collection technique, it is important to review available information on the adolescent client's experience with such methods as first-void urine (FVU) and the self-collected vaginal swab. In one study, adolescents readily accepted urine-testing methods but no comparisons against any other testing methods were presented.17 Two other studies showed that teenagers preferred the self-collected swab test to the pelvic examination.9,10 However, to our knowledge, no study to date has evaluated the adolescent's preferences after experiencing multiple distinct STD screening techniques simultaneously. Therefore, this study was designed specifically to examine adolescents' preferences for and attitudes toward 3 different STD screening techniques: the FVU, the self-collected vaginal swab test, and the pelvic examination.
Participants were recruited from adolescent women attending either a university- or health maintenance organization-based clinic for adolescents. Non–English speakers were ineligible to participate.
Human subject use review boards at both participating institutions approved this study. Participants were recruited on 3 afternoons per week when most pelvic examinations were scheduled. All young women who were at the clinic for pelvic examination were approached to participate by a trained female research assistant and gave standard demographic recruitment information and signed a consent form.
Participants were instructed on the proper collection of the FVU (first 20 mL in marked cup) and vaginal specimens (insert swab 1-2 in, rotate around vagina 3 times; repeat procedure with second swab), and then underwent a pelvic examination, at which time 2 endocervical swab samples were obtained by the clinician.
The FVU, 1 vaginal, and 1 endocervical swab specimen (a second endocervical swab specimen was processed in parallel in the hospital laboratory per routine) were assayed for C trachomatis and N gonorrhoeae (LCx®; Abbott Laboratories, Chicago, Ill) in the laboratory of one of the authors (J.S.) The second self-collected vaginal swab sample was tested for Trichomonas vaginalis using the Trichomonas In-Pouch TV (Biomed Diagnostics, San Jose, Calif) according to the manufacturer's instructions. Participants were considered to have a specific STD if any specimen yielded a positive result from either laboratory. Result discrepancies between laboratories were not significant.
Before STD specimen collection, the research assistant obtained demographic information (age, ethnicity, household makeup, work experience, and grade in school) on all potential participants using a recruitment survey. All surveys were piloted for correct wording and content on 26 adolescent females attending the target clinics. Following the recruitment survey, a preexamination survey on reproductive health was given, which consisted of 10 items about the participant's sexual and reproductive history (ie, sexual risk behaviors, pregnancy, and contraceptive history).
Finally, each participant took part in a postexamination interview in which she was asked to rank the 3 STD testing techniques by preference. She was then asked to rate 10 statements (Table 1) according to how well they described her experience with each testing method (5 positive and 5 negative items) using a 10-point scale (1 = disagree completely and 10 = agree completely with description). These descriptors were developed during the pilot phase and were the most common terms elicited from an open-ended query (ie, "Describe what you like and dislike about each method").
To analyze rankings, the Friedman test was conducted to evaluate differences in medians among the 3 methods (this tests the null hypothesis, ie, no difference in preference among the 3 methods). Scores for each variable (pelvic examination, vaginal swab, and FVU) were ranked (first choice = 1, second choice = 2, and third choice = 3) and median ranks for variables were compared (the lower the ranking, the higher the preference). For significant findings (P<.05), Wilcoxon rank sum follow-up tests were conducted to evaluate comparisons between pairs of medians and controlled for the type I errors across these comparisons at the .05 level. This procedure was used for the total population and for specific subgroups (regular tampon use, condom use at last intercourse, past pelvic examination, and prior pregnancy).
To analyze qualitative descriptors of each testing method, within-subject repeated-measures analyses of variance were used. Because this design gathered responses from each participant for each of the 3 testing methods, within-subject differences could be analyzed, with between-subject differences removed. This method first calculates the mean for each participant for each method and then examines the mean differences for the testing techniques being compared. To adjust for multiple comparisons, a 97.5% confidence interval was used for these analyses.
A total of 189 sexually active young women who were to have a pelvic examination on the day of the visit were invited to participate. One hundred fifty-five patients participated (mean age, 16.7 years; range, 12-21 years). They were racially/ethnically diverse: 34% were African American, 19% were white, 17% were Asian American, 13% were Latin American, and 17% were of mixed or other races. Those who refused to participate (n = 34) gave the following reasons for nonparticipation: lack of time (n = 12), unwillingness to do the vaginal swab test (n = 11), pelvic examination discomfort (n = 4), confidentiality concerns (n = 1), and 6 cited other miscellaneous reasons. Those who refused were older (mean age, 17.39 vs 16.70 years; P = .01) and more likely to be African American (59% vs 34%; P = .01) than participants.
Reasons for the visit included (>1 response possible) annual pelvic examination (54%), STD screen (40%), contraception (28%), pregnancy test (15%), other gynecologic problems (9%), and reasons not related to reproductive health (13%). Clinical diagnoses included normal results in 69% of patients, reproductive health–related in 29%, and other nonreproductive diagnoses in 2%. Sexually transmitted diseases detected included C trachomatis (6.1%), N gonorrhoeae (3.1%), and T vaginalis (4.7%).
The median rank for the FVU method was significantly lower (greater preference) (median, 1.59) than the self-collected vaginal swab (median, 2.01) and the pelvic examination (median, 2.39) (Table 2). There were no differences in rankings by prior pelvic examination, regular tampon use, condom use at last sexual intercourse, age, ethnicity, or prior STD history. When asked what they liked and disliked about each method, using a list of 5 positive and 5 negative descriptors, the participants scored the pelvic examination more negatively and the FVU more positively, with the vaginal swab method scoring slightly less positively than the FVU (Table 1). In general, they felt more comfortable and less embarrassed with the FVU and vaginal swab methods compared with the pelvic examination and described more pain and inconvenience with the pelvic examination compared with the other methods. However, they trusted the results of the pelvic examination more than the vaginal swab and FVU methods (P<.001). Participants seemed to worry that they might self-administer the vaginal swab test incorrectly, thus having less faith in that test compared with the FVU (P<.001) and pelvic examinations (P<.05).
Participants ranked the pelvic examination last, the self-collected vaginal swab method second, and the FVU first in preference for STD screening (Table 2). This preference was upheld in analyses of subgroups with more reproductive experiences, eg, tampon use and prior pelvic examination. The pelvic examination, the current standard of care for STD screening, not only was ranked last by preference but also was consistently evaluated highest for the negative attributes, such as anxiety and pain, and lowest for the positive attributes, such as comfort and control over collection method. This last-place finish for the pelvic examination occurred even though most participants were prescheduled for a pelvic examination and most had prior pelvic examination experience. In contrast, the self-collected vaginal swab method was ranked higher than the pelvic examination on both preference and the participants' evaluation profiles regarding negative and positive attributes; yet, none of the participants had prior self-collected swab experience. Analyses of the vaginal swab method revealed one unique result compared with the other methods: participants more often felt that they might be "doing something wrong" during the collection compared with the other methods. In addition, 11 of those initially approached (6%) refused to participate in the study because of concern about the self-collected swab component (only persons having a pelvic examination were approached to participate, which potentially yielded a more positive bias toward the pelvic examination since those who refused were not approached to participate in the study). Participants clearly preferred the FVU as the method of choice for STD screening. In addition, participants scored the FVU lowest on negative attributes (eg, least anxious or painful) and highest on positive attributes (eg, most comfortable or most relaxed) compared with the other methods.
This study illustrates the importance of including the young consumer's preferences and attitudes when developing new STD screening strategies. There exist only a handful of studies reporting success in alternative STD specimen collection methods for adolescents.7-10,17 Although our study supports adolescents' acceptance of alternative methods of STD screening, the participants' responses were not uniformly positive for each method. For example, some participants were fearful that they were doing the vaginal sampling wrong and were more confident with the results of the pelvic examination. They also trusted the results of the pelvic examination more than those of the FVU. The FVU method, while preferred by these adolescents, is not a perfect specimen from a system's perspective: it is more difficult to store, transport (requires cold chain maintenance), and process (requires additional laboratory steps) compared with the vaginal or endocervical swab methods (which can be mailed in), resulting in increased laboratory costs. The performance of the vaginal swab method is more comparable with that of the endocervical swab in detecting chlamydial infections, and both perform slightly better than the FVU.8-10,17 Although generally ranked last on most parameters, the pelvic examination was uniformly chosen as the most trusted method of screening by the adolescent, which may reflect tradition and the overall interaction with the clinician during a pelvic examination. A major limitation of this study is the generalizability of the findings beyond the clinical setting.
In summary, chlamydia is a major public health concern in the female adolescent. With urine and vaginal sampling possible for STD screening, the invasive, costly, time-consuming, and often uncomfortable pelvic examination can now be reserved to obtain a Papanicolaou smear as needed and to assess pregnancy and gynecologic pathology as warranted. A revolution of STD testing is at hand but more research is needed to look at barriers to STD screening from all aspects of the health care system before consumer-friendly universal STD screening can be successful.
Accepted for publication February 14, 2002.
This study was supported by funding from the Yen Chuang Foundation, San Francisco, Calif, and Dr Shafer was supported in part by grant MC00003 from the Maternal and Child Health Bureau, Rockville, Md.
We thank Biomed Diagnostics for providing the InPouch™ TV test kits.
New nucleic acid amplification–based STD testing techniques are more accurate and cost-effective. However, little investigation has been done to assess the adolescent consumer's acceptance of different specimen collection techniques. A few available studies have found that adolescents readily accept FVU and vaginal swab testing methods. To our knowledge, this is the first study specifically designed to examine adolescents' preferences for and attitudes toward 3 different STD screening techniques after experiencing each technique in parallel during a clinic visit: the FVU sample, the self-collected vaginal swab technique, and the pelvic examination with endocervical sampling.
Corresponding author: Mary-Ann Shafer, MD, University of California–San Francisco, School of Medicine, Department of Pediatrics, Division of Adolescent Medicine, Box 0503, San Francisco, CA 94143-0503 (e-mail: firstname.lastname@example.org).
Serlin M, Shafer M, Tebb K, et al. What Sexually Transmitted Disease Screening Method Does the Adolescent Prefer?Adolescents' Attitudes Toward First-Void Urine, Self-collected Vaginal Swab, and Pelvic Examination. Arch Pediatr Adolesc Med. 2002;156(6):588–591. doi:10.1001/archpedi.156.6.588